Home / Import refusals / SCS-2067066-9/11/2

FDA Import Refusal SCS-2067066-9/11/2 — GlaxoSmithKline LLC

GlaxoSmithKline LLC — FEI 1033964

The FDA refused shipment SCS-2067066-9/11/2 from GlaxoSmithKline LLC (United States) on October 5, 2020. The refused product falls under Drugs and Biologics — ANTI-ASTHMATIC, N.E.C.. Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
October 5, 2020
Country
United States
Product Category
Drugs and Biologics
Product Code
61ECY99 ANTI-ASTHMATIC, N.E.C.
Charges
75

Recent inspections

  • 1298596 (NAI Fri Feb 20 2026 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1229588 (VAI Fri Apr 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1043270 (NAI Fri Jan 26 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 987392 (VAI Thu Apr 21 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 940149 (NAI Fri Aug 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time))

Other import refusals

  • 1FX-0333205-3/10002/1 (Fri Jun 12 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 1FX-9324952-1/30002/1 (Tue Jun 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • NUV-3881703-0/70002/1 (Tue Feb 24 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-9318923-9/110002/1 (Thu Feb 19 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-9449370-5/10003/1 (Fri Feb 06 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources